The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia.
暂无分享,去创建一个
M. Keating | J. Burger | W. Wierda | L. Miller | N. Giese | B. Lannutti | M. Sivina | H. Kantarjian | A. Yu | S. A. Meadows | J. Hoellenriegel | S. O’Brien | Julia Hoellenriegel